All Type of News
The Korea Pharmaceutical Manufacturers Association will enforce the secret voting to sort out rebate-suspicious companies
It seems that the pharmaceutical industry will conduct a secret vote to sort out companies operating rebate businesses as scheduled in April.
According to the industry concerned, the Korea Pharmaceutical Manufacturer...
Advertising expenses of listed pharmaceutical companies exceeded KRW 400 billion last year
It is studied that listed pharmaceutical companies spent more than KRW 400 billion for advertisements due to several reasons such as invigoration of OTC drugs diversification of advertisement channels.
Moreover, it i...
On the controversy over the Ildong Pharmaceutical’s management against Green Cross, Ildong was able to smileIldong Pharmaceutical has successfully defended the management.
The proposal to appoint internal director (CEO and president Jung-chi Lee of Ildong Pharmaceutical) and outside ...
|
New changes are expected as emergence of internal promotions, recruits, a woman and second generations as CEOs
Approximately 40 pharmaceutical companies held shareholders’ general meetings and board meetings on the last 20th, the first woman professional manager has emerged, and personnel from multinational pharmaceutical comp...
The strong of OTC drugs, Dongwha Pharm, expanded to CNS infections
The oldest company, Dongwha Pharm, has domestically acquired an approval for the new quinolones-type antibiotic for the third time after Factive and Q-Roxin.
On the last 20th, Dongwha has acquired a product approval ...
The members chose the ‘Innovation with Stability’
Moo-jin Choi, the current president of The Korean Medical Association, has been elected as the 39th president.
As a result of the 39th President Election of the Korean Medical Association on the 20th, President Choi ...
As the Patent Linkage System is enforced, pharmaceutical companies have continued to apply for lawsuits
Due to enforcement of the Patent Linkage System, it is known that pharmaceutical companies have shown active movements to meet the requirement for the very first lawsuit and the very first approval application.
Accor...
Green Cross vs Ildong Pharmaceutical, ‘would it be success of Green Cross or defense of Ildong Pharmaceutical?’The shareholders’ general meeting of Ildong Pharmaceutical (the 20th) has attracted attention of the pharmaceutical industry.
Triggered by the shareholder proposal of Green Cro...
|
The Korean Pharmaceutical Association requested to repeal the ‘OTC Drug Price Disclosure System’
The Korean Pharmaceutical Association (KPA) raised its voice of concern on the comparison of commonly-consumed OTC drugs in black and white.
The KPA unveiled through the position statement announced on the 19th that ...
Hanmi Pharm is developing the salt alteration product of Tamifly to avoid the patentHanmi Pharm has begun to develop the salt alteration product of the flu treatment, Tamiflu.
This is because it is trying to avoid the Roche’s salt patent for Tamiflu; the decis...
|
